A study published in Nature found that blood cell mutations linked to leukemias become inevitable as people age, especially in the Japanese population. The research identified genetic variations associated with increased risk of these mutations, which can be detected through a simple blood test.
Scientists have identified long-concealed genetic mutations in tomatoes using a new technique called long-read sequencing. The analysis reveals that these mutations can alter key characteristics such as flavor and weight. By studying the impact of these mutations, researchers hope to create new tomato varieties with improved traits.
Researchers at the University of Maryland School of Medicine have identified a new genetic defect linked to amyotrophic lateral sclerosis (ALS), a devastating condition causing progressive paralysis and mental deterioration. The discovery may lead to new treatments for ALS, with potential implications for other neurodegenerative diseases.
Researchers used a new genetic engineering technique, known as base editing, to repair a single mutation in the Tmc1 gene, restoring partial hearing in mice. The technique has potential for treating other genetic forms of hearing loss and diseases.
A new study from UCL-led researchers has identified the earliest brain changes due to Huntington's disease, detecting damage 24 years before clinical symptoms appear. The findings provide vital insights into the optimal time to initiate treatments, potentially delaying or preventing neurodegeneration.
A new study compares the distribution of mutations in human tumours to those in chimpanzees and gorillas. The research reveals that human tumours accumulate mutations in regions similar to those found in non-human primates, challenging previous theories on the genetic causes of cancer.
Researchers identified a new gut-brain connection in ALS, finding that altering the gut microbiome can prevent or improve disease symptoms in mice with a common genetic mutation. The study suggests that the gut microbiome may influence disease severity and could be a target for therapy.
A recent study by University of Zurich researchers has identified a key mechanism controlling brain development and cognitive function. The study found that a lipid metabolism enzyme, fatty acid synthase (FASN), regulates the lifelong activity of brain stem cells, leading to reduced division and learning deficits.
A new subtype of myelodysplastic syndromes (MDS) has been proposed based on the presence of a genetic mutation, known as SF3B1. This subtype is characterized by ineffective production of red blood cells and may benefit from treatment with luspatercept.
Researchers have identified ATP10B as a novel risk gene for Parkinson's disease, revealing its role in transporting glucosylceramide, a lipid critical to the disease's pathogenesis. Mutations in this gene can lead to neuronal loss and increased sensitivity to environmental risk factors.
A study has uncovered a mechanism explaining how genetic mutations lead to nephrotic syndrome, a rare genetic kidney disorder. The researchers found that disruptions in the recycling of cell membranes cause abnormal kidney cell structure and function.
Researchers identified a novel mutation in the S6K1 enzyme that affects protein synthesis and is associated with altered cognitive abilities in children with autism spectrum disorder. The study found that this mutation changes the course of normal neural development and memory forming capacity.
Researchers identified 15 potent tumor suppressor genes that, when mutated, triggered rapid growth of HNSCC in mice. These genes include ADAM10 and AJUBA, which are also mutated in human HNSCC. The study reveals the identity of rare driver mutations in tumor-suppressing genes using a mouse-based CRISPR screen.
A recent study of over 4,500 postmenopausal women diagnosed with breast cancer found that about 1 in 40 have BRCA1 or BRCA2 gene mutations. These mutations increase the risk of other cancers, including ovarian cancer, and may benefit from genetic testing.
Scientists have found that 'silent' genetic variations in DNA sequences can significantly impact protein folding, impairing cell function. The study, conducted by the University of Notre Dame, used a bacterium to test this hypothesis, finding that synonymous mutations can alter protein synthesis rates.
A new data analysis tool has been developed to study the formation of zebrafish stripes, enabling scientists to objectively test ideas about how patterns are formed. The algorithm uses topological data analysis to quantify attributes of shapes and patterns, providing a more objective approach to understanding developmental processes.
Researchers identified a genetic mutation affecting cellular oxygen sensing and a patient's limited exercise capacity. The von Hippel-Lindau gene is fundamental for cells to survive in low-oxygen conditions, and its impaired functionality limits the patient's exercise capacity compared to those without the mutation.
Researchers question the idea that human language arose instantaneously through a single gene mutation, proposing instead a gradual evolution through accumulation of smaller biological changes. They argue that the cognitive operation Merge, key to human language, evolved gradually over time.
A clinical research program at Columbia University Irving Medical Center will treat eight more ALS patients with FUS mutations using the investigational therapy jacifusen. The program aims to expand access to treatments for rare ALS subtypes associated with gene mutations.
Researchers resurrected mammoth DNA and found unique genetic mutations affecting neurological development, male fertility, insulin signaling, and sense of smell. The study suggests that the small population's genetic defects may have hindered their survival.
Researchers identified germline mutations in the MBD4 gene as a driver of somatic mutations in cancer genomes, accelerating the clock-like mutational process. This discovery has significant implications for understanding cancer development and may lead to personalized screening and early intervention strategies.
A genetic study of schizophrenia in South African Xhosa individuals reveals a higher prevalence of rare damaging mutations in those with the disorder. The findings provide insights into the universal nature of human biology and can inform new treatments for schizophrenia.
A research team has identified a mechanism that triggers a rare type of muscular dystrophy, Limb-girdle muscular dystrophy (LGMD) 1G. The study reveals that a specific protein isoform with two domains is prone to forming toxic aggregates, while another isoform with three domains can prevent aggregation through phase separation.
A new study of Asian genes aims to improve disease treatment and care by shedding light on human migration history. The research will create detailed reference databases for Asian populations, helping medical researchers identify genetic differences that can cause diseases.
A team of researchers created the first cellular model of chronic granulomatous disease (CGD), a rare genetic condition that causes severe infections. The study's findings suggest that restoring NADPH oxidase function in defective cells could help develop new and more effective treatment strategies.
Researchers at UNIGE discovered a new gene linked to blindness and cardiomyopathy, which causes a deficiency in taurine. Administering a taurine supplement halted the progression of eye disease and treated cardiac disease in two children.
Researchers used CRISPR gene-editing to introduce human mutations into C. elegans worms, identifying genes that modify disease progression and pinpointing harmful drugs. The study found three candidate disease-modifier genes and demonstrated the importance of screening for potential harm in patients with genetic mutations.
A new study suggests that rare, harmful genetic mutations present in healthy donors' stem cells can be passed on to cancer patients, causing heart damage, graft-versus-host disease and new leukemias. The study analyzed DNA samples from 25 AML patients and their matching donors, revealing 44% of donors had at least one harmful mutation.
A recent WSU study discovered a rare genetic mutation in greyhounds that affects their ability to break down certain anesthetics, but also found similar mutations in popular breeds like golden retrievers and Labrador retrievers. The research team is working on a simple cheek swab test to detect the mutation and provide accurate advice ...
A new genetic test approach may help diagnose Emery-Dreifuss muscular dystrophy and other rare diseases by identifying mutations that trigger muscle-wasting conditions. The study identified over 20 new mutations linked to the condition, which affects around one in 100,000 people worldwide.
Splice-altering mutations can contribute to inherited predisposition to cancer by altering RNA splicing patterns. The cBROCA method identifies altered transcripts and associated genes, revealing potential therapeutic targets.
Researchers at Tel Aviv University have discovered a significant overlap between genetic mutations causing autism and those related to Alzheimer's disease. The study found thousands of mutations in the aging brains of Alzheimer's patients, including those affecting the protein ADNP.
Researchers discovered a rare gene mutation in the DUOX2 gene associated with familial thyroid cancer, which increases the risk of hereditary non-medullary thyroid cancer. The mutated protein produces excess hydrogen peroxide, potentially causing additional genetic mutations and increasing cancer risk.
Researchers identified 22 new mutations in the TITIN gene associated with non-ischemic dilated cardiomyopathy, a disease weakening the heart muscle. Patients with these mutations had severe cardiomyopathy and poorer outcomes, highlighting the need for genetic testing and aggressive monitoring.
A recent study has identified the gene function that protects against type 2 diabetes, revealing a zinc transporter's role in insulin secretion. The research found that individuals with a specific mutation in the SLC30A8 gene have enhanced glucose-stimulated insulin secretion and reduced blood sugar levels.
A comprehensive genome sequencing study reveals rare CFTR mutations in Puerto Rican and Dominican patients, driving the disease's progression. This finding underscores the need for diverse clinical trials to develop personalized therapies, as transformative new drugs may not benefit minority populations.
Researchers discovered a genetic variant in the Epas1 gene that enables high-altitude deer mice to survive by increasing their heart rate in response to low oxygen levels. This adaptation is also found in Tibetans living at high altitudes, suggesting potential benefits for long-term survival.
Researchers developed an algorithm that uses nonsense-mediated mRNA decay (NMD) to predict which cancer patients will respond to immunotherapy. NMDdetective identifies mutations in the genome susceptible to this quality control process, allowing for personalized treatment approaches.
A genetic test can now be developed for the mutation discovered in the RAPGEF6 gene in miniature bull terriers. The study identifies an important role for RAPGEF6 in laryngeal nerve function, with carriers of the mutation having a 10- to 17-fold increased risk of laryngeal paralysis.
Researchers found complex patterns of mutations, including changes in cancer genes, and a huge variability of mutations in healthy colon tissue. The study provides insight into how a healthy cell becomes a cancerous one and identifies new mutational signatures in normal colon cells.
A genetic link has been discovered between Sudden Infant Death Syndrome (SIDS) and a mutation in the HADHA gene, causing infants to die suddenly from cardiac arrest. Researchers hope that this discovery will lead to new treatments and interventions for the disease.
A new study published in Nature found that a single genetic mutation in the SF3B1 gene is associated with an increased risk of developing various types of cancer. The researchers discovered that this mutation leads to the production of abnormal RNA molecules, including noncoding DNA sequences that disrupt the genetic message.
A genetic variant in the DNMT3A region of chromosome 2p appears to help people with MRSA clear blood stream infections by regulating immune response. The mutation reduces levels of anti-inflammatory cytokine IL-10, allowing for a more effective host response.
A study published in Nature Communications reveals that inherited germline variations and somatic mutations interact to determine the course of Ewing sarcoma disease. The research, led by Dr. Thomas Grünewald, shows how genetic context influences tumor growth and progression.
Researchers at Ohio State University have found a link between a genetic mutation and flu-related heart complications in mice. The study suggests that some people may be genetically predisposed to these complications, which could lead to new therapies.
A new study published in Nature found that only a few individuals of the thale cress plant have adapted to extreme climate conditions, suggesting a potential collapse of species genetic diversity in Central Europe. This could lead to reduced plant populations unable to survive due to changing precipitation and temperature patterns.
A study by Massachusetts General Hospital researchers has found a mutation in the RABL3 gene linked to hereditary forms of pancreatic cancer. The discovery may lead to earlier diagnoses and improved treatments for patients with strong family histories.
Researchers developed an advanced method to detect low-level somatic mutations in intractable epilepsy with 100% accuracy, surpassing conventional sequencing analysis which stands at 30%. The study used deep sequencing replicates of major focal epilepsy genes and identified mutations in approximately 5% of patients.
Scientists have discovered a rare, inherited gene mutation that significantly increases the risk of pancreatic and other cancers. The RABL3 mutation was found in a family with multiple relatives diagnosed with pancreatic cancer, and zebrafish carrying the mutation also showed dramatically higher rates of cancer.
A study led by UCSF found that advanced sleep phase, where people wake up at 4 a.m., may be more common than previously thought, affecting around 1 in 300 adults. This condition is distinct from early rising with normal aging and can improve daytime functioning.
Researchers identified the molecular mechanism linking a protein mutation with abnormal nervous system development in neurodevelopmental disorders. A complex of proteins called the SWI/SNF complex was found to be affected, leading to changes in gene expression and brain development.
Researchers found that slowing metabolic rates can prevent developmental problems caused by genetic mutations in fruit flies. The study suggests that reducing metabolism by 50% allows for adjustment and correction of errors, thereby preventing detrimental effects.
Researchers identified a repeated stretch of DNA as the cause of four rare neurodegenerative diseases, including fragile X tremor/ataxia syndrome and Parkinson's disease. The discovery uses advanced DNA sequencing technology and may lead to insights into other diseases caused by similar mutations.
Researchers discovered 43 specific genetic mutations required for leukemia development in children with Down syndrome. The study identified additional genetic changes transforming preleukaemic cells into leukaemic ones.
Researchers find that targeting a specific genetic mutation can alleviate psychosis symptoms by restoring glutamate function and glycine levels. The study provides proof-of-principle for a new approach to treating psychotic disorders using genotype-based treatment.
Researchers at Harvard Medical School developed a precise gene-editing tool to target the faulty Tmc1 gene in Beethoven mice, achieving an unprecedented level of accuracy. The treatment successfully preserved hearing in mice with hereditary deafness, paving the way for potential treatments of other dominantly inherited genetic diseases.
A study by Massachusetts General Hospital found that DNA single strands can be highly sensitive to mutation by gene-editing enzymes. Many mutations occur in genes unrelated to cancer development, highlighting the need to distinguish between 'driver' and 'passenger' mutations.
The PREGCARE study provides personalized pre-conception risk evaluation for healthy couples with a child affected by a developmental disorder. The researchers aim to identify families at high risk of recurrence and provide accurate assessment of their chances of having an unaffected child.
Researchers analyzed genomic data from over 31,000 parent-child trios and identified 307 significantly enriched genes, 49 of which are novel. The study explains about 51% of the DNM burden in their dataset, leaving half unexplained, providing clues for future discovery.
A study has identified new potential genetic causes of male infertility, which will help develop better diagnostic tests. Researchers found de novo mutations in genes involved in spermatogenesis, none of which were previously known to cause human infertility.